Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.02.2026 21:59:13
Orthofix Med Rg (NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
13,37 0,72 0,10 787 050
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 14.02.2026
Popis společnosti
Obecné informace
Název společnostiOrthofix Medical Inc
TickerOFIX
Kmenové akcie:Ordinary Shares
RICOFIX.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 31.12.2024 1 616
Akcie v oběhu k 31.10.2025 39 599 659
MěnaUSD
Kontaktní informace
Ulice3451 Plano Pkwy
MěstoLEWISVILLE
PSČ75056-9453
ZeměUnited States
Kontatní osobaJulie Dewey
Funkce kontaktní osobyChief Investor Relations and Communications Officer
Telefon12 149 372 000
Fax13026365454

Business Summary: Orthofix Medical Inc. is a global medical technology company. The Company offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Orthofix Medical Inc revenues increased 3% to $602.4M. Net loss decreased 7% to $90M. Revenues reflect Others segment increase from $16.2M to $36M, Italy segment increase from $5.3M to $11.3M. Lower net loss reflects Other income (expense), net increase from $6.3M (expense) to $6.4M (income), Fair Value Adjustments on Other decrease from $6.2M (expense) to $1.8M (income).
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Equipment, Supplies & Distribution (NEC)
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSMedical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICSSpecialty (except Psychiatric and Substance Abuse) Hospitals
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Surgical Appliance & Supplies Mfg
NAICS2007Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Surgical Appliance and Supplies Manufacturing
NAICS1997Medical, Dental and Hospital Equipment and Supplies Wholesalers
SICSurgical And Medical Instruments
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies
SICMedical And Hospital Equipment
SICSpecialty Hospitals Not Psych'Ric
SICElectromedical Equipment



  • Poslední aktualizace: 14.02.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorMassimo Calafiore5308.01.202408.01.2024
Chief Financial OfficerJulie Andrews5415.01.202415.01.2024
President - Global OrthopedicsPatrick Fisher5115.08.202415.08.2024
President - Global SpineMax Reinhardt5411.06.202411.06.2024
Chief People and Business Operations OfficerLucas Vitale4918.03.202418.03.2024
Chief Accounting OfficerGeoffrey Gillespie5215.01.202412.09.2023
Chief Investor Relations and Communications OfficerJulie Dewey6111.06.202411.06.2024
Chief Legal OfficerJ. Andres Cedron4416.04.202416.04.2024